Divine Aleru, Microbiome Signatures Research Coordinator

This review explains how Clostridium perfringens enterotoxin causes gastrointestinal disease by binding claudins and forming pores in intestinal epithelial cells. Toxin production during sporulation disrupts gut barrier integrity, promotes diarrhea, and contributes to microbiome-associated disease, especially following antibiotic exposure or microbial imbalance.

This study shows that toxin-neutralizing antibodies protect against Clostridium perfringens intestinal damage by blocking alpha toxin and perfringolysin O. These toxins drive microbiome-associated tissue necrosis, and antibody neutralization prevents cell death and infection progression.

This review explains how Clostridium perfringens toxins disrupt microbiome-host interactions by damaging cell membranes, forming pores, and activating intracellular pathways that cause cell death, inflammation, and disease. These toxin-driven mechanisms represent key microbiome signatures associated with infection severity and pathogenic progression.

This study shows that microbiome nutrients such as arginine, zinc, and vitamins regulate alpha-toxin production in Clostridium perfringens. Toxin production depends on specific nutrient conditions rather than bacterial growth alone, establishing microbiome nutrient balance as a key determinant of virulence and infection risk.

This study shows that FeoB iron transport controls Clostridium perfringens growth, toxin production, and microbiome survival. Iron acquisition regulates virulence, metabolism, and infection risk, making FeoB a key microbiome signature linked to pathogenic fitness and disease severity.

This review explains how NetB toxin enables Clostridium perfringens to shift from a gut microbiome commensal to a toxin-producing pathogen. NetB disrupts intestinal epithelial barriers, promotes bacterial dominance, and drives necrotic enteritis, highlighting toxin detection and microbiome stability as key targets for disease prevention.

This review explains how Clostridium perfringens uses toxin production, plasmid gene transfer, and microbiome colonization to cause intestinal and systemic disease. Virulence regulation, sporulation, and quorum sensing allow rapid pathogenic expansion, highlighting microbiome disruption and toxin gene detection as key clinical risk factors.

This review explains how Clostridium perfringens type F causes gastrointestinal disease through microbiome colonization, sporulation, and enterotoxin production. The toxin disrupts intestinal epithelial barriers, enabling infection, inflammation, and diarrhea, highlighting toxin detection and microbiome stability as key factors in preventing foodborne and antibiotic-associated gastrointestinal disease.

This guideline explains how microbiome-derived pathogens cause skin and soft tissue infections and highlights key microbial signatures linked to severe disease.

This review explains how Clostridium spores enable microbiome survival, toxin production, and infection through sporulation and germination.

This review shows how Clostridium perfringens sporulation enables toxin production, microbiome persistence, and intestinal disease.

This study shows that zinc stabilizes Clostridium perfringens alpha-toxin and protects it from protease degradation, while calcium promotes protease production that destroys toxin. These microbiome metal ion interactions regulate toxin activity, virulence, and infection risk.

This review explains how Clostridium perfringens uses sporulation to survive microbiome stress, resist antibiotics, and transmit infection between hosts. Sporulation enables toxin production, microbiome persistence, and disease progression. Spores resist environmental and immune defenses, allowing long-term survival and increasing risk of infection recurrence and transmission.

This study shows how the pCW3 plasmid enables transfer of tetracycline resistance and toxin genes in Clostridium perfringens, identifying key microbiome mechanisms driving resistance and virulence spread.

This review explains how mobile plasmids drive antibiotic resistance and toxin spread in Clostridium perfringens, identifying key microbiome mechanisms behind treatment resistance and pathogenicity.

This review explains how Clostridium perfringens epsilon toxin activates in the gut microbiome and causes brain injury, vascular damage, and systemic disease.

This study defines how the NetB toxin from Clostridium perfringens forms membrane pores and drives enteric disease, linking toxin structure to microbiome-associated virulence and epithelial damage.

This review explains how Clostridium perfringens causes necrotic disease through microbiome disruption, toxin production, and immune suppression. Microbiome imbalance increases pathogen abundance, while microbial metabolites can reduce virulence, highlighting microbiome stability as a key protective factor and therapeutic target in necrotic enteritis and systemic infection.

This genome sequencing study revealed how Clostridium perfringens survives in the gut microbiome and causes disease. Virulence genes, toxin regulation, and host-dependent metabolism enable tissue destruction and rapid growth, highlighting microbiome-driven pathogenicity and identifying genetic targets for improved diagnostics and therapeutic interventions.

This genomic study identified a Clostridium perfringens strain carrying both enterotoxin and NetB toxin genes, revealing microbiome-driven virulence evolution through plasmid transfer. The findings highlight microbiome gene exchange as a key driver of pathogenicity and emphasize the need for genomic surveillance to detect emerging toxin-producing strains.

This genomic study of 372 Clostridium perfringens strains revealed extreme genetic diversity, widespread toxin genes, and high antimicrobial resistance. Microbiome-associated virulence factors enable host colonization, intestinal disease, and zoonotic transmission, highlighting the importance of microbiome surveillance and genomic diagnostics to prevent foodborne illness and antibiotic-resistant infections.

This review explains how Clostridium perfringens shifts from a gut microbiome commensal to a toxin-producing pathogen. Genomic diversity, toxin genes, antibiotic resistance, and microbiome disruption drive gastrointestinal disease, including food poisoning and necrotizing enterocolitis, highlighting its importance as a microbiome biomarker and therapeutic target.

This review explains how Clostridium perfringens functions as a gut microbiome commensal and toxin-producing pathogen. Toxin genes, plasmid virulence, antimicrobial resistance, and microbiome disruption drive gastrointestinal disease, antibiotic-associated diarrhea, and food poisoning, highlighting the importance of toxin detection and microbiome stability in clinical management.

Fusobacterium nucleatum is a Gram-negative, anaerobic bacterium commonly found in the oral cavity, where it plays a crucial role in the formation of biofilms. Beyond its presence in the mouth, Fn is implicated in a variety of systemic conditions, including periodontal disease, colorectal cancer, and inflammatory bowel disease. Known for its ability to coaggregate with other bacteria, Fn’s pathogenic potential is magnified in dysbiotic microbial communities, making it a key player in polymicrobial infections. The bacterium utilizes multiple virulence factors such as FadA and Fap2, which facilitate adhesion to host tissues and immune evasion, ultimately contributing to its role in chronic and inflammatory diseases.